Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 9
Submit an article Journal homepage
586
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Secondary malignancy after imatinib therapy: eight cases and review of the literature

Berna Bozkurt DumanDepartment of Medical OncologyCorrespondence[email protected]
,
Semra PaydasDepartment of Medical Oncology
,
Umut DiselDepartment of Medical Oncology, Faculty of Medicine, Başkent University, Adana, Turkey
,
Ayberk BesenDepartment of Medical Oncology, Faculty of Medicine, Başkent University, Adana, Turkey
&
Emel GurkanDepartment of Hematology, Faculty of Medicine, Çukurova University, Adana, Turkey
Pages 1706-1708 | Received 13 Sep 2011, Accepted 08 Feb 2012, Published online: 02 Apr 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zhimei Cai, Shuo Liu, Jie Zi, Jinlong Ma & Zheng Ge. (2019) A case of primary gastric diffuse large B-cell lymphoma occurring in chronic myeloid leukemia. OncoTargets and Therapy 12, pages 5917-5923.
Read now
Xiangdong Xu & Anjum Hassan. (2014) Extranodal marginal zone lymphoma arising in a patient with chronic myelogenous leukemia on long-term tyrosine kinase inhibitors. Leukemia & Lymphoma 55:3, pages 715-717.
Read now
Brady L. Stein. (2012) Chronic myeloid leukemia and risk of second malignancy in two eras of treatment. Leukemia & Lymphoma 53:9, pages 1651-1653.
Read now

Articles from other publishers (11)

Yoann Zelmat & Fabien Despas. (2023) Drug-induced tumoral disease: A global pharmacovigilance database analysis. Therapies.
Crossref
Anurag Singh, Nida Shabbir, Tanya Tripathi, Rashmi Kushwaha & Shailendra P Verma. (2023) A Rare Case of Metastatic Small Cell Carcinoma of Lung in a Follow-Up Patient of Chronic Myeloid Leukemia on Imatinib Treatment. Cureus.
Crossref
Kaveripakam Ajay Joseph, Sana Ahuja & Sufian Zaheer. (2023) Secondary Ovarian Malignancy in an Imatinib treated Chronic Myeloid Leukemia Patient Diagnosed on Fluid Cytology. Clinical Cancer Investigation Journal 12:4, pages 10-13.
Crossref
Nidhi Mehra, Armon Varmeziar, Xinyu Chen, Olivia Kronick, Rachel Fisher, Vamsi Kota & Cassie S. Mitchell. (2022) Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Cancers 14:19, pages 4686.
Crossref
Chang-Hoon Lee, So Yeon Jeon, Ho-Young Yhim, Kyu Yun Jang & Jae-Yong Kwak. (2020) Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors. Medicine 99:19, pages e19962.
Crossref
Wafaa M Rashed, Anas Saad, Muneer Al-Husseini, Ahmed Mahmoud Galal, Assem Mohamed Ismael, Ahmed M Al-Tayep, Ayman El Shafie, Mahmoud Ahmed Ali & Ahmad Samir Alfaar. (2018) Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. Endocrine Connections 7:10, pages 1040-1048.
Crossref
Vivek Kumar, Mohit Garg, Neha Chaudhary & Abhinav Binod Chandra. (2018) An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States. PeerJ 6, pages e4342.
Crossref
Hannah BowerMagnus BjörkholmPaul W. DickmanMartin HöglundPaul C. LambertTherese M.-L. Andersson. (2016) Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. Journal of Clinical Oncology 34:24, pages 2851-2857.
Crossref
Lauren Caldemeyer, Michael Dugan, John Edwards & Luke Akard. (2016) Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports 11:2, pages 71-79.
Crossref
Alicja M. Gruszka, Cristina Rabascio, Laura Cannella, Simona Sammassimo, Giovanna Andreola, Giuliana Gregato, Mario Faretta, Angelica Calleri, Rita De Molfetta, Giancarlo Pruneri, Francesco Bertolini & Myriam Alcalay. (2015) Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma – a case report. Scientific Reports 5:1.
Crossref
Catherine A. Moroski-Erkul, Burak Yilmaz, Esra Gunduz & Mehmet Gunduz. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer 17 40 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.